Paclitaxel in Treating Patients With Early-Stage Bladder Cancer
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I/II trial to study the effectiveness of paclitaxel in treating patients with
early-stage bladder cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Mary Babb Randolph Cancer Center at West Virginia University Hospitals